Nuclear coexpression of NF-kB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium

Ling Li; Zijun Y Xu-Monette; Chi Young Ok; Ganiraju C Manyam; Carlo Visco; Alexander Tzankov; Santiago Montes-Moreno; Karen Dybkær; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D. Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; John P Farnen; Michael B. Møller; Miguel A. Piris; Jane N. Winter; L Jeffrey Medeiros; Ken H Young

doi:10.1016/j.clml.2015.04.101

Nuclear coexpression of NF-kB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium

Ling Li, Zijun Y Xu-Monette, Chi Young Ok, Ganiraju C Manyam, Carlo Visco, Alexander Tzankov, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L Richards, Eric D. Hsi, William W L Choi, J Han van Krieken, Jooryung Huh, Maurilio Ponzoni, Andrés J M Ferreri, John P FarnenMichael B. Møller, Miguel A. Piris, Jane N. Winter, L Jeffrey Medeiros, Ken H Young

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

362 Citationer (Scopus)

Originalsprog	Engelsk
Artikelnummer	516
Tidsskrift	Clinical Lymphoma, Myeloma & Leukemia
Vol/bind	15
Udgave nummer	Suppl. 1
Sider (fra-til)	S224
Antal sider	1
ISSN	2152-2650
DOI	https://doi.org/10.1016/j.clml.2015.04.101
Status	Udgivet - 2015
Begivenhed	Annual Meeting of the Society of Hematologic Oncology - Houston, USA Varighed: 17 sep. 2014 → 20 sep. 2014 Konferencens nummer: 2

Konference

Konference	Annual Meeting of the Society of Hematologic Oncology
Nummer	2
Land/Område	USA
By	Houston
Periode	17/09/2014 → 20/09/2014

Adgang til dokumentet

10.1016/j.clml.2015.04.101

http://www.sciencedirect.com/science/article/pii/S2152265015002591

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Li, L., Xu-Monette, Z. Y., Ok, C. Y., Manyam, G. C., Visco, C., Tzankov, A., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Han van Krieken, J., Huh, J., Ponzoni, M., Ferreri, A. J. M., ... Young, K. H. (2015). Nuclear coexpression of NF-kB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium. Clinical Lymphoma, Myeloma & Leukemia, 15(Suppl. 1), S224. Artikel 516. https://doi.org/10.1016/j.clml.2015.04.101

Li, Ling ; Xu-Monette, Zijun Y ; Ok, Chi Young et al. / Nuclear coexpression of NF-kB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy : A Report from the International DLBCL Rituximab-CHOP Consortium. I: Clinical Lymphoma, Myeloma & Leukemia. 2015 ; Bind 15, Nr. Suppl. 1. s. S224.

@article{c3ff97a4d8e24d59b83c7af75c2c4241,

title = "Nuclear coexpression of NF-kB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium",

author = "Ling Li and Xu-Monette, {Zijun Y} and Ok, {Chi Young} and Manyam, {Ganiraju C} and Carlo Visco and Alexander Tzankov and Santiago Montes-Moreno and Karen Dybk{\ae}r and April Chiu and Attilio Orazi and Youli Zu and Govind Bhagat and Richards, {Kristy L} and Hsi, {Eric D.} and Choi, {William W L} and {Han van Krieken}, J and Jooryung Huh and Maurilio Ponzoni and Ferreri, {Andr{\'e}s J M} and Farnen, {John P} and M{\o}ller, {Michael B.} and Piris, {Miguel A.} and Winter, {Jane N.} and Medeiros, {L Jeffrey} and Young, {Ken H}",

year = "2015",

doi = "10.1016/j.clml.2015.04.101",

language = "English",

volume = "15",

pages = "S224",

journal = "Clinical Lymphoma, Myeloma & Leukemia",

issn = "2152-2650",

publisher = "Elsevier",

number = "Suppl. 1",

note = "Annual Meeting of the Society of Hematologic Oncology ; Conference date: 17-09-2014 Through 20-09-2014",

}

Li, L, Xu-Monette, ZY, Ok, CY, Manyam, GC, Visco, C, Tzankov, A, Montes-Moreno, S, Dybkær, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, KL, Hsi, ED, Choi, WWL, Han van Krieken, J, Huh, J, Ponzoni, M, Ferreri, AJM, Farnen, JP, Møller, MB, Piris, MA, Winter, JN, Medeiros, LJ & Young, KH 2015, 'Nuclear coexpression of NF-kB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium', Clinical Lymphoma, Myeloma & Leukemia, bind 15, nr. Suppl. 1, 516, s. S224. https://doi.org/10.1016/j.clml.2015.04.101

Nuclear coexpression of NF-kB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium. / Li, Ling; Xu-Monette, Zijun Y; Ok, Chi Young et al.
I: Clinical Lymphoma, Myeloma & Leukemia, Bind 15, Nr. Suppl. 1, 516, 2015, s. S224.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Nuclear coexpression of NF-kB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy

T2 - Annual Meeting of the Society of Hematologic Oncology

AU - Li, Ling

AU - Xu-Monette, Zijun Y

AU - Ok, Chi Young

AU - Manyam, Ganiraju C

AU - Visco, Carlo

AU - Tzankov, Alexander

AU - Montes-Moreno, Santiago

AU - Dybkær, Karen

AU - Chiu, April

AU - Orazi, Attilio

AU - Zu, Youli

AU - Bhagat, Govind

AU - Richards, Kristy L

AU - Hsi, Eric D.

AU - Choi, William W L

AU - Han van Krieken, J

AU - Huh, Jooryung

AU - Ponzoni, Maurilio

AU - Ferreri, Andrés J M

AU - Farnen, John P

AU - Møller, Michael B.

AU - Piris, Miguel A.

AU - Winter, Jane N.

AU - Medeiros, L Jeffrey

AU - Young, Ken H

N1 - Conference code: 2

PY - 2015

Y1 - 2015

U2 - 10.1016/j.clml.2015.04.101

DO - 10.1016/j.clml.2015.04.101

M3 - Conference abstract in journal

SN - 2152-2650

VL - 15

SP - S224

JO - Clinical Lymphoma, Myeloma & Leukemia

JF - Clinical Lymphoma, Myeloma & Leukemia

IS - Suppl. 1

M1 - 516

Y2 - 17 September 2014 through 20 September 2014

ER -

Li L, Xu-Monette ZY, Ok CY, Manyam GC, Visco C, Tzankov A et al. Nuclear coexpression of NF-kB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium. Clinical Lymphoma, Myeloma & Leukemia. 2015;15(Suppl. 1):S224. 516. doi: 10.1016/j.clml.2015.04.101